Related Experiment Video
Updated: Apr 12, 2026

Peptides from Phage Display Library Modulate Gene Expression in Mesenchymal Cells and Potentiate Osteogenesis in Unicortical Bone Defects
Published on: December 10, 2010
Increased osteoblast Gα11 level compromises bone healing quality by suppressing high-density bone formation
Kathy K Lee1, Adele Changoor2, Marc D Grynpas3
1Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.
Abstract:
Gαq/11 proteins that couple G protein-coupled receptors to stimulate phospholipase C play important roles in the skeletal system as previously demonstrated by bone abnormalities when activating mutations or when overexpression of these G proteins occur in mice or humans. Here we investigated the effect of increased Gα11 in osteoblastic cells on bone fracture repair in transgenic (G11-Tg) mice in comparison to wild type (WT). Following stabilized tibial osteotomies in male mice, fracture healing was examined weekly over 4 weeks by micro-CT, histomorphometry, and gene expression analysis and bone biomechanics after 4 weeks. Histomorphometry showed diminished cartilage in G11-Tg mice at peak soft callus formation. Histology showed diminished osteoblasts on the healing bone of G11-Tg mice throughout the 4 weeks ending with lower bone volume and bone mineral content as seen by micro-CT. Consistent with the lower amounts of cartilage and bone, mRNAs encoding chondrocyte proteins, Sox 9, Col 2a1 and Col 10a1 were significantly lower in G11-Tg compared to WT at week 1. From 2 to 4 weeks Runx2, the master regulator of osteoblasts, and osteocalcin, a mature osteoblast marker, were significantly lower in G11-Tg than in WT. Osteoclasts were not significantly different between G11-Tg and WT. After 4 weeks, torsion testing showed significantly lower yield torque and torsional stiffness in G11-Tg compared to WT. Together our results show that increased Gα11 inhibits endochondral bone development following fracture by suppressing both chondrocyte and osteoblast formation resulting in mechanically weaker bone.
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Remodeling
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Osteoclasts in Bone Remodeling
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Bone Remodeling and Repair

